Effect of acetyl-L-carnitine on VIP-ergic neurons in the jejunum submucous plexus of diabetic rats

Arquivos de Neuro-Psiquiatria

Volumn 61, Issue 4, 2003, Pages 962-967

  Defani, Marli Aparecida ^a,b   Zanoni, Jacqueline Nelisis ^a,b   Natali, Maria Raquel Marçal ^a,b   Bazotte, Roberto Barbosa ^a,b   De Miranda Neto, Marcílio Hubner ^a,b  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b Department of Sciences ^*

Author keywords

Acetyl L carnitine; Diabetes; Jejunum; Rat; Submucous plexus; VIP

Indexed keywords

LEVACECARNINE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; STREPTOZOCIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG MECHANISM; IMMUNOREACTIVITY; INTESTINE INNERVATION; JEJUNUM; MALE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; RAT; RAT STRAIN; STREPTOZOCIN DIABETES;

EID: 0348148916     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2003000600014     Document Type: Article

References (25)

1. Lowitt S, Malone JI, Salem AF, Korthals J, Benford DS. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 1995;5:677-680.
2. Nakamura J, Koh N, Sakakibara F, et al. Polyol pathway hyperactivity is closely to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. J Pharmacol Exp Therap 1998;287:897-902.
3. Ballmann M, Conlon JM Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat. Diabetologia 1985;28:355-358.
4. Belai A, Burnstock G. Changes in adrenergic and peptidergic nerves in the submucous plexus of the streptozotocin-diabetic rat ileum. Gastroenterology 1990;98:1427-1436.
5. Dockray GJ. Physiology of enteric neuropeptides In Johnson LR (ed). Physiology of the gastrointestinal tract. New York Raven, 1994:169-209.
6. Belai A, Linconl J, Milner P, Crowe A, Loesch A, Burnstock G. Enteric nerves in diabetic rats: increase in vasoative intestinal polypeptide but not substance P. Gastroenterology 1985;89:967-976.
7. Modlin IM, Bloom SR, Mitchell SJ. Experimental evidence for vasoative intestinal peptide as the cause of the watery-diarrhoea syndrome. Gastroenterology 1978;75:1051-1054.
8. Belai A, Facer P, Bishop A, Polak JM, Burnstock G. Effect of streptozotocin-diabetes on level of VIP mRNA in myenteric neurones. Neuroreport 1993;4:291-294.
9. Ferrannini E, Buzzigli G, Bevilacqua S, et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 1988;255:946-952.
10. Stevens MJ, Feldman EL, Greene DA. The aetoliogy of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabetic Med 1995;12:566-579.
11. Bergmeyer HU, Bernet E. Determination of glucose-oxidase and peroxidase. In Methods of enzymatic analysis. New York Academic Press, 1974.
12. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerani A. Correlation of glucose regulation and hemoglobin Alc in diabetes mellitus. N Engl J Med 1976;295:417-420.
13. Stefanini M, Demartino C, Zamboni C. Fixation of ejaculated spermatozoa for electron microscopy. Nature 1967;216:173-174.
14. Costa M, Buffa R, Furness JB, Solcia E. Imunohistochemical localization of polypeptides in pheripheral autonomic nerves using whole mount preparations. Histochemistry 1980;65:157-165.
15. Zanoni JN, Hernandes L, Bazotte RB, Miranda - Neto MH. Terminal ileum submucous plexus: study of the VIP-ergic neurons of diabetic rats treated with ascorbic acid. Arq Neuropsiquiatr 2002;60:32-37.
16. Gorio A, DI Giulio AM, Tenconi B, et al. Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine. Int J Clin Pharm Res 1992;12:225-230.
17. Belai A, Calcutt NA, Carrington AL, Diemel LT, Tomlinson DR, Burnstock G: Enteric neuropeptides in streptozotocin-diabetes rats: effects of insulin and aldose reductase inhibition. J Auton Nerv Syst 1996;58:163-169.
18. Hotta N, Koh N, Sakakibara F, et al. Effects of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. J Pharmacol Exp Ther 1996;276:49-55.
19. See NA, Epstein ML, Dahl JL, Bass P. The myenteric plexus regulates cell growth in rat jejunum. J Auton Nervous Syst 1990;31:219-229.
20. Furness JB, Costa AM. The enteric nervous system, New York, Churchil Livingstone, 1987.
21. Zanoni JN, Miranda - Neto MH, Bazotte RB, Souza RR. Morphological and quantitative analysis of the neurons of the myenteric plexus of the cecum of streptozotocin-induced diabetic rats. Arq Neuropsiquiatr 1997;55:696-702.
22. Hernandes L, Bazotte RB, Gama P, Miranda-Neto MH. Streptozotocin-induced diabetes duration is important to detemune changes in the number and basophily of myenteric neurons. Arq Neuropsiquiatr 2000;58:1035-1039.
23. Romano BE, Miranda - Neto MH, Cardoso RCS. Preliminary investigation about the effects of streptozotocin-induced chronic diabetes on the nerve cell number and size of myenteric ganglia in rat colon. Rev Chil Anat 1996;14:139-145.
24. Fregonesi CEPT, Miranda-Neto MH, Molinari SL. Estudo morfológico e quantitativo dos neurônios do plexo mientérico do corpo do estômago de Rattus norvegicus. Acta Scientiarum 1998;20:221-24.
25. Fregonesi CEPT, Miranda-Neto MH, Molinari SL, Zanoni JN. Quantitative study of the myenteric plexus of the stomach of rats with streptozotocin-induced diabetes. Arq Neuropsiquiatr 2001;59:50-53.